Szerző: " Vranckx Pascal"

Vissza
Export [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Találatok száma: 2.

Tomaniak Mariusz; Chichareon Ply; Onuma Yoshinobu; Deliargyris Efthymios N.; Takahashi Kuniaki; Kogame Norihiro; Modolo Rodrigo; Chang Chun Ching; Rademaker-Havinga Tessa; Storey Robert F.; Dangas George D.; Bhatt Deepak L.; Angiolillo Dominick J.; Hamm Christian; Valgimigli Marco; Windecker Stephan; Steg Philippe Gabriel; Vranckx Pascal; Serruys Patrick W.; GLOBAL LEADERS Trial Investigators; Ungi Imre; Merkely Béla Péter; Horváth Iván (kollab. közrem.): Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
JAMA CARDIOLOGY, 4 (11). pp. 1092-1101. ISSN 2380-6583 (2019)

Gargiulo Giuseppe; Patialiakas Athanasios; Piccolo Raffaele; Thury Attila; Colangelo Salvatore; Campo Gianluca; Tebaldi Matteo; Ungi Imre; Tondi Stefano; Roffi Marco; Menozzi Alberto; de Cesare Nicoletta; Garbo Roberto; Meliga Emanuele; Testa Luca; Gabriel Henrique Mesquita; Ferlini Marco; Liistro Francesco; Dellavalle Antonio; Vranckx Pascal; Briguori Carlo; Windecker Stephan; Valgimigli Marco: Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 277. pp. 60-65. ISSN 0167-5273 (2019)

A lista elkészítésének dátuma 2024. március 28. 10:11:39 CET.